Animal Health Market Size, Share & Analysis Report, 2022-2030
The global Animal Health market size was estimated at USD 39.9 billion in 2021 and is expected to surpass around USD 92.8 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 10.4% during the forecast period 2022 to 2030.
Key Takeaways:
The market is driven by technological advancements in veterinary care, which are anticipated to offer the market future growth opportunities. For instance, MediLabSecure, a laboratory network project, was initiated with an aim of identifying emerging viruses and pathogens in 19 countries in the Mediterranean regions. In addition, the emergence of veterinary health information systems, specifically in developed economies, is expected to provide high growth potential in the future.
With the help of these systems, data generated in veterinary clinics can be uploaded on the internet, which can be further shared with other researchers and clinicians. The incorporation of this technology will facilitate real-time analysis for fluctuations in disease prevalence. As a consequence of the aforementioned factors, it is presumed that there will be a significant improvement in the overall penetration rate of veterinary health products, which is anticipated to fuel market demand as well as revenue. The threat of zoonotic infections spreading through mosquitoes, ticks, and fleas or through contact with animals is high. The WHO is involved in various cross-sectoral activities for the purpose of addressing health threats at the human-animal-ecosystem interface.
Food-borne zoonoses, antimicrobial resistance, and emerging zoonoses are some of the threats in the market. The implementation of a wide range of technologies for the detection and monitoring of various animal diseases is one of the major growth contributing factors. North America captured a substantial share in the global market, owing to a wide range of definitive measures adopted by welfare organizations, technological advancements, rising incidence of zoonotic diseases, and an increasing number of pet owners. Asia Pacific is expected to exhibit lucrative growth over the coming years as a consequence of consistent R&D investments deployed by prominent players and their efforts to commercialize branded and generic therapeutics at a relatively inexpensive price.
Key market participants employ sustainability strategies, such as expanding product portfolio, to gain a competitive advantage. For instance, in January 2021, Zoetis launched the Poulvac Procerta HVT-IBD vaccine for the protection of poultry against Infectious Bursal Disease (IBD). This added to Zoetis’ product portfolio of recombinant vector vaccines.
Report Scope of the Animal Health Market
|
Report Coverage |
Details |
|
Market Size |
USD 92.8 Billion by 2030 |
|
Growth Rate |
CAGR of 10.4% from 2022 to 2030 |
|
Largest Market |
North America |
|
Fastest Growing Market |
Asia Pacific |
|
Base Year |
2021 |
|
Forecast Period |
2022 to 2030 |
|
Segments Covered |
Animal Type, product, distribution channel, end use And Geography, |
|
Companies Mentioned |
Merck Animal Health, Ceva Sante Animale, Vetoquinol S.A., Zoetis, Boehringer Ingelheim GmbH, Elanco, IDEXX, Heska Corporation, Covetrus, DRE Veterinary, Mars Inc., Virbac, Televet, Phibro Animal Health Corporation, B.Braun Vet Care, Dechra Pharmaceuticals PLC, Bimeda, Inc., Midmark Corporation, Thermo Fisher Scientific, Inc., IDVet |
Product Insights
The pharmaceutical segment dominated the market for animal health and held the largest revenue share of over 34.1% in 2021. It is estimated to retain its dominant position throughout the forecast period on account of consistent advancements in veterinary drugs. Pharmaceuticals primarily include anti-inflammatory drugs, parasiticides, antibiotics, and others. It is also believed that a considerable increase in companion animal ownership has also expedited the adoption of pharmaceuticals to help increase longevity. Moreover, an increasing number of mergers and acquisitions, for instance, the acquisition of Bayer by Elanco has resulted in the multimarket distribution of their products, including pharmaceuticals. Mergers and acquisitions are considered one of the key factors contributing to segment growth over the years.
The veterinary diagnostics segment is expected to witness significant growth over the forecast period. Various factors such as growing animal health expenditure, rising incidence of zoonotic diseases, and increasing number of veterinary practitioners and their incomes in developed economies are also responsible for market growth. Companies are investing in the expansion of their manufacturing facilities, which is expected to positively influence the market for animal health over the forecast period. There has been an increase in the demand for point-of-care diagnostics, such as blood glucose monitors, pregnancy kits, and urinalysis strips, by pet owners. Food animal diagnostics remain confined to labs due to high sensitivity and efficacy requirements in disease testing.
The others segment is expected to witness the fastest CAGR of 17.1% from 2022 to 2030. This segment is inclusive of the other vet care products and services such as grooming, veterinary telehealth, veterinary software, livestock monitoring, and others. Growing R&D activities for the development of better and more efficient products are anticipated to boost the market for animal health. Besides, market growth is driven by the growing prevalence of diseases among companion animals, increasing focus on animal health among pet owners, growing animal health expenditure, increasing population of companion animals, rising demand for pet insurance, and the increasing number of the veterinary surgeon and income levels in developed economies.
Animal Type Insights
The production animal segment dominated the market for animal health and accounted for the largest revenue share of over 65.0% in 2021. The substantial share captured by the segment can be presumed a consequence of high concern for food safety and sustainability by government healthcare organizations globally. Policymakers in various countries are striving to achieve total food security, which propels large-scale food production and results in greater rearing of livestock. The policies are focused on long-term sustainability, which can be achieved through a combination of improving productivity and greater attention to livestock veterinary healthcare.
According to Food and Agriculture Organization, in the emerging economies, animal-based food products account for one-third of human protein consumption, leading to an increase in livestock productivity, which is critical to meet the dietary needs of the growing human population. These factors cumulatively are responsible for the significant share captured by production animals in this segment. The companion animal segment is expected to grow lucratively during the forecast period owing to an increase in demand for efficient animal care and the pet-human bond due to the associated health benefits. Companion animals are known to lower blood pressure, provide psychological stability, and reduce the frequency of cardiac arrhythmias and anxiety attacks, which enhance the overall well-being of humans. Consequentially, animal-assisted therapy is increasingly preferred as a result of these companion animal products, which, in turn, is likely to drive the segment in the coming years.
Distribution Channel Insights
The veterinary hospital pharmacy segment accounted for a revenue share of over 51.0% in 2021. The increasing number of hospital pharmacies, coupled with high procedural volume as a consequence of frequent readmission of pets for treatment, has supported segment growth. Retail channels and e-commerce platforms also accounted for a significant share of the total market. The e-commerce segment is anticipated to witness exponential growth throughout the forecast period. This can be attributed to various advantages such as increased convenience for patients not willing to purchase medicines from retail or hospital pharmacies.
Moreover, these also facilitate a consistent supply of drugs, as medications can be preordered. Benefits such as these are anticipated to accentuate the demand for e-commerce throughout the forecast period. With the help of online pharmacies, order procurement and tracking become easy as associated Supply Chain Management (SCM) eliminates other market intermediaries of the delivery channel. This reduces overall costs, thereby increasing customer preference. Retail pharmacies for animal health products are expected to grow at a moderate rate throughout the forecast period.
Major manufacturers rely on only licensed veterinarians and authorized distributors for the distribution of medications and vaccines. This is anticipated to propel segment growth over the forecast period. E-commerce/online pharmacies selling animal health products are anticipated to witness exponential growth throughout the forecast period. This growth is believed to be a result of various advantages such as increased convenience for patients not willing to purchase medicines from retail or hospital pharmacies.
End-use Insights
The veterinary hospitals and clinics segment accounted for the largest revenue share of over 73.9% in 2021. The dominant share captured by this segment is a consequence of various applications such as clinical pathology, toxicology tests, and therapy. The availability of a wide range of treatment as well as diagnostic options in veterinary hospitals and clinics is a high-impact rendering growth driver for this segment. An increase in the incidence of zoonotic diseases caused by globalization and climate changes is expected to drive the demand for diagnostic procedures, which is expected to drive the point-of-care testing/in-house testing segment in the coming years.
The increase in initiatives to create awareness among companion animal owners about the benefits and value of preventive care in pets is one of the key contributing factors to in-house testing in animal health. Tests such as ELISA have been proven an effective point-of-care tests for heartworm diagnosis. Certain vaccines are only available in accredited veterinary hospitals and clinics, which is responsible for increasing the share of this end-user segment. Various government animal welfare organizations have issued guidelines for safety practices and standards to be implemented in veterinary hospitals and clinics, which has broadened the scope for segment growth over the past few years.
Regional Insights
North America dominated the market for animal health and accounted for the largest revenue share of 30.5% in 2021, owing to the wide range of definitive measures adopted by government animal welfare organizations that are consistently working for overall improvement in animal health. Furthermore, technological advancements, the rising incidence of zoonotic diseases, and an increasing number of pet owners are expected to boost the market growth in this country. Several collaborative efforts by major companies to enhance their R&D capabilities and ensure high-quality standards are anticipated to impel the demand further across this region. Moreover, the majority share can also be attributed to the high disease burden in this region.
In Asia Pacific, the market for animal health is expected to register a lucrative CAGR of 10.9% over the coming years. The high growth registered by this region is believed to be a consequence of consistent R&D investments by prominent players in the field of animal health and their efforts to commercialize branded and generic therapeutics at a relatively inexpensive price. The exponential growth is owing to growing awareness pertaining to pet nutrition and supplies and increasing disposable income.
Some of the prominent players in the Animal Health Market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Animal Health market
By Geography
North America
Europe
<span style="font-
Chapter 1. Introduction
1.1 Segment Market Scope
1.1.1 Type
1.1.2 Product
1.1.3 Distribution Channel
1.1.4 End Use
1.1.5 Regional Scope
1.1.6 Estimates & Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Nova one advisor’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.3.5.1 Data for primary interviews in North America
1.3.5.2 Data for primary interviews in Europe
1.3.5.3 Data for primary interviews in Asia Pacific
1.3.5.4 Data for primary interviews in Latin America
1.3.5.5 Data for primary interviews in MEA
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
Approach 2: Volume Price Analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
Chapter 2 Executive Summary
2.1 Market Summary, 2021
2.1.1 Market Outlook
2.1.2 Segment Outlook
Chapter 3 Animal Health Market Variables, Trends & Scope
3.1 Animal Health Market Dynamics
3.1.1 Market Driver Analysis
3.1.1.1 Increase in Government Initiatives
3.1.1.2 Rapid Technological advancements
3.1.1.3 Growing focus on animal health and safety
3.1.2 Market Restraint Analysis
3.1.2.1 Increasing Influx of Counterfeit Drugs
3.1.2.2 Lack of Standardization
3.2 Business Segment Trends
3.2.1 Animal Health Market, Animal Type Outlook: Key Takeaways
3.2.2 Animal Health Market, Product Outlook: Key Takeaways
3.2.3 Animal Health Market, Distribution Channel Outlook: Key Takeaways
3.2.4 Animal Health Market, End-Use Outlook: Key Takeaways
3.3 Business Environment Analysis Tools
3.3.1 SWOT Analysis, By Factor (Political & Legal, Economic & Technological)
3.3.1.1 Political Landscape
3.3.1.2 Economic Landscape
3.3.1.3 Social Landscape
3.3.1.4 Technology Landscape
3.3.1.5 Legal Landscape
3.3.2 Porter’s Five Forces Analysis
3.3.2.1 Supplier Power
3.3.2.2 Buyer Power
3.3.2.3 Threat of Substitutes
3.3.2.4 Threat of New Entrants
3.3.2.5 Competitive Rivalry
3.3.3 Value Chain Analysis
3.3.4 Investments In Animal Health
3.3.5 Pet Animal Owner Profiles
3.3.6 Cost Structure Analysis
Chapter 4 Regulatory & Political Forces
4.1 Regulatory Framework
4.1.1 List of Regulations
Chapter 5 Competitive & Vendor Landscape
5.1 Participation Categorization
5.2 Strategic Initiatives & Outcome Analysis
5.2.1 List Of Key Strategies, By Company
5.3 Major Deals & Acquisitions
5.4 Vendor Landscape
5.4.1 List Of Distributors
5.5 List of Animal Health Drugs
5.6 Company Market Share Analysis, 2021
5.7 Public Companies
5.7.1 Company Market Position Analysis
5.8 Market Share Analysis by Country, 2021
5.8.1 North America
5.8.2 Europe
5.8.3 Asia Pacific
5.8.4 Latin America
5.8.5 MEA
Chapter 6 Animal Health Market: Animal Type Estimates and Trend Analysis
6.1 Animal Health Market: Animal Type Movement Analysis
6.2 Production Animal
6.2.1 Production Animal Market Estimates And Forecasts, 2017 - 2030
6.2.2 Poultry
6.2.2.1 Poultry Market Estimates And Forecasts, 2017 - 2030
6.2.3 Swine
6.2.3.1 Swine Market Estimates And Forecasts, 2017 - 2030
6.2.4 Cattle
6.2.4.1 Cattle Market Estimates And Forecasts, 2017 - 2030
6.2.5 Sheep & Goats
6.2.5.1 Sheep & Goats Market Estimates And Forecasts, 2017 - 2030
6.2.6 Fish
6.2.6.1 Fish Market Estimates And Forecasts, 2017 - 2030
6.3 Companion Animal
6.3.1 Companion Animal Market Estimates And Forecasts, 2017 - 2030
6.3.2 Dogs
6.3.2.1 Dogs Market Estimates And Forecasts, 2017 - 2030
6.3.3 Cats
6.3.3.1 Cats Market Estimates And Forecasts, 2017 - 2030
6.3.4 Horses
6.3.4.1 Horses Market Estimates And Forecasts, 2017 - 2030
6.3.5 Others
6.3.5.1 Others Market Estimates And Forecasts, 2017 - 2030
Chapter 7 Animal Health Market: Product Estimates & Trend Analysis
7.1 Animal Health Market: Product Movement Analysis
7.2 Vaccines
7.2.1 Vaccines Market Estimates And Forecasts, 2017 - 2030
7.2.2 Live Attenuated Vaccines
7.2.2.1 Live Attenuated Vaccines Market Estimates And Forecasts, 2017 - 2030
7.2.3 DNA Vaccines
7.2.3.1 DNA Vaccines Market Estimates And Forecasts, 2017 - 2030
7.2.4 Recombinant Vaccines
7.2.4.1 Recombinant Vaccines Market Estimates And Forecasts, 2017 - 2030
7.2.5 Inactivated Vaccines
7.2.5.1 Inactivated Vaccines Market Estimates And Forecasts, 2017 - 2030
7.2.6 Others
7.2.6.1 Others Market Estimates and Forecasts, 2017 - 2030
7.3 Pharmaceuticals
7.3.1 Pharmaceuticals Market Estimates and Forecasts, 2017 - 2030
7.3.2 Parasiticides
7.3.2.1 Parasiticides Market Estimates and Forecasts, 2017 - 2030
7.3.3 Anti-Infectives
7.3.3.1 Anti-Infectives Market Estimates and Forecasts, 2017 - 2030
7.3.4 Anti-Inflammatory
7.3.4.1 Anti-Inflammatory Market Estimates and Forecasts, 2017 - 2030
7.3.5 Analgesics
7.3.5.1 Analgesics Market Estimates and Forecasts, 2017 - 2030
7.3.6 Others
7.3.6.1 Others Market Estimates and Forecasts, 2017 - 2030
7.4 Medicial Feed Additives
7.4.1 MFA Market Estimates And Forecasts, 2017 - 2030
7.5 Diagnostics
7.5.1 Diagnostics Market Estimates And Forecasts, 2017 - 2030
7.5.2 Instruments
7.5.2.1 Instruments Market Estimates and Forecasts, 2017 - 2030
7.5.3 Consumables
7.5.3.1 Consumables Market Estimates and Forecasts, 2017 - 2030
7.6 Equipment & Disposables
7.6.1 Equipment & Disposables Market Estimates And Forecasts, 2017 - 2030
7.6.2 Critical Care
7.6.2.1 Critical Care Market Estimates and Forecasts, 2017 - 2030
7.6.3 Anesthesia Equipment
7.6.3.1 Anesthesia Equipment Market Estimates and Forecasts, 2017 - 2030
7.6.4 Fluid Management Equipment
7.6.4.1 Fluid Management Equipment Market Estimates and Forecasts, 2017 - 2030
7.6.5 Temperature Management Equipment
7.6.5.1 Temperature Management Equipment Market Estimates and Forecasts, 2017 - 2030
7.6.6 Rescue & Resuscitation Equipment
7.6.6.1 Rescue & Resuscitation Equipment Market Estimates and Forecasts, 2017 - 2030
7.6.7 Research Equipment
7.6.7.1 Research Equipment Market Estimates and Forecasts, 2017 - 2030
7.6.8 Patient Monitoring Equipment
7.6.8.1 Patient Monitoring Equipment Market Estimates and Forecasts, 2017 - 2030
7.7 Others
7.7.1 Other Animal Health Products Market Estimates and Forecasts, 2017 - 2030
7.7.2 Veterinary telehealth
7.7.2.1 Veterinary Telehealth Market Estimates and Forecasts, 2017 - 2030
7.7.3 Veterinary Software
7.7.3.1 Veterinary Software Market Estimates and Forecasts, 2017 - 2030
7.7.4 Livestock Monitoring
7.7.4.1 Livestock Monitoring Market Estimates and Forecasts, 2017 - 2030
Chapter 8 Animal Health Market: Distribution Channel Estimates & Trend Analysis
8.1 Animal Health Market: Distribution Channel Movement Analysis
8.1.1 Retail
8.1.2 Retail Market Estimates and Forecasts, 2017 - 2030
8.2 E-commerce
8.2.1 E-Commerce Market Estimates and Forecasts, 2017 - 2030
8.3 Veterinary Hospitals & Clinics
8.3.1 Veterinary Hospitals & Clinics Market Estimates and Forecasts, 2017 - 2030
Chapter 9 Animal Health Market: End-use Estimates & Trend Analysis
9.1 Animal Health Market: End-Use Movement Analysis
9.2 Reference Laboratories
9.2.1 Reference Laboratories Market Estimates and Forecasts, 2017 - 2030
9.3 Point-of-care Testing/In-house Testing
9.3.1 Point-of-Care Testing/In-House Testing Market Estimates And Forecasts, 2017 - 2030
9.4 Veterinary Hospitals & Clinics
9.4.1 Veterinary Hospitals & Clinics Market Estimates and Forecasts, 2017 - 2030
9.5 Others
9.5.1 Others Market Estimates and Forecasts, 2017 - 2030
Chapter 10 Animal Health Market: Regional Estimates & Trend Analysis, by Animal Type, Product, Distribution Channel, End-use
10.1 Animal Health Market Shares By Region, 2021 & 2030
10.2 North America
10.2.1 North America Animal Health Market Estimates And Forecasts, 2017 - 2030
10.2.2 U.S.
10.2.2.1 U.S. Animal Health Market Estimates and Forecasts, 2017 - 2030
10.2.3 Canada
10.2.3.1 Canada Animal Health Market Estimates and Forecasts, 2017 - 2030
10.3 Europe
10.3.1 Europe Animal Health Market Estimates And Forecasts, 2017 - 2030
10.3.2 U.K.
10.3.2.1 U.K. Animal Health Market Estimates And Forecasts, 2017 - 2030
10.3.3 Germany
10.3.3.1 Germany Animal Health Market Estimates And Forecasts, 2017 - 2030
10.3.4 France
10.3.4.1 France Animal Health Market Estimates And Forecasts, 2017 - 2030
10.3.5 Italy
10.3.5.1 Italy Animal Health Market Estimates And Forecasts, 2017 - 2030
10.3.6 Russia
10.3.6.1 Russia Animal Health Market Estimates And Forecasts, 2017 - 2030
10.3.7 Spain
10.3.7.1 Spain Animal Health Market Estimates And Forecasts, 2017 - 2030
10.3.8 Netherlands
10.3.8.1 Netherlands Animal Health Market Estimates And Forecasts, 2017 - 2030
10.3.9 Switzerland
10.3.9.1 Switzerland Animal Health Market Estimates And Forecasts, 2017 - 2030
10.3.10 Sweden
10.3.10.1 Sweden Animal Health Market Estimates And Forecasts, 2017 - 2030
10.3.11 Ireland
10.3.11.1 Ireland Animal Health Market Estimates And Forecasts, 2017 - 2030
10.3.12 Poland
10.3.12.1 Poland Animal Health Market Estimates And Forecasts, 2017 - 2030
10.4 Asia Pacific
10.4.1 Asia Pacific Animal Health Market Estimates And Forecasts, 2017 - 2030
10.4.2 Japan
10.4.2.1 Japan Animal Health Market Estimates And Forecasts, 2017 - 2030
10.4.3 China
10.4.3.1 China Animal Health Market Estimates And Forecasts, 2017 - 2030
10.4.4 India
10.4.4.1 India Animal Health Market Estimates And Forecasts, 2017 - 2030
10.4.5 Indonesia
10.4.5.1 Indonesia Animal Health Market Estimates And Forecasts, 2017 - 2030
10.4.6 Thailand
10.4.6.1 Thailand Animal Health Market Estimates And Forecasts, 2017 - 2030
10.4.7 Australia
10.4.7.1 Australia Animal Health Market Estimates And Forecasts, 2017 - 2030
10.4.8 South Korea
10.4.8.1 South Korea Animal Health Market Estimates And Forecasts, 2017 - 2030
10.4.9 Philippines
10.4.9.1 Philippines Animal Health Market Estimates And Forecasts, 2017 - 2030
10.4.10 Malaysia
10.4.10.1 Malaysia Animal Health Market Estimates And Forecasts, 2017 - 2030
10.4.11 Singapore
10.4.11.1 Singapore Animal Health Market Estimates And Forecasts, 2017 - 2030
10.5 Latin America
10.5.1 Latin America Animal Health Market Estimates And Forecasts, 2017 - 2030
10.5.2 Mexico
10.5.2.1 Mexico Animal Health Market Estimates And Forecasts, 2017 - 2030
10.5.3 Brazil
10.5.3.1 Brazil Animal Health Market Estimates And Forecasts, 2017 - 2030
10.5.4 Argentina
10.5.4.1 Argentina Animal Health Market Estimates And Forecasts, 2017 - 2030
10.6 MEA
10.6.1 MEA Animal Health Market Estimates And Forecasts, 2017 - 2030
10.6.2 South Africa
10.6.2.1 South Africa Animal Health Market Estimates And Forecasts, 2017 - 2030
10.6.3 Saudi Arabia
10.6.3.1 Saudi Arabia Animal Health Market Estimates And Forecasts, 2017 - 2030
10.6.4 Turkey
10.6.4.1 Turkey Animal Health Market Estimates And Forecasts, 2017 - 2030
10.6.5 Iran
10.6.5.1 Iran Animal Health Market Estimates And Forecasts, 2017 - 2030
10.6.6 United Arab Emirates
10.6.6.1 United Arab Emirates Animal Health Market Estimates And Forecasts, 2017 - 2030
10.6.7 Israel
10.6.7.1 Israel Animal Health Market Estimates And Forecasts, 2017 - 2030
Chapter 11 Company Profiles
11.1 Merck Animal Health
11.1.1 Company Overview
11.1.2 Financial Performance
11.1.3 Product Benchmarking
11.1.4 Strategic Initiatives
11.2 Ceva Santé Animale
11.2.1 Company Overview
11.2.2 Financial Performance
11.2.3 Product Benchmarking
11.2.4 Strategic Initiatives
11.3 Vetoquinol S.A.
11.3.1 Company Overview
11.3.2 Financial Performance
11.3.3 Product Benchmarking
11.3.4 Strategic Initiatives
11.4 Zoetis
11.4.1 Company Overview
11.4.2 Financial Performance
11.4.3 Product Benchmarking
11.4.4 Strategic Initiatives
11.5 Boehringer Ingelheim GmbH
11.5.1 Company Overview
11.5.2 Financial Performance
11.5.3 Product Benchmarking
11.5.4 Strategic Initiatives
11.6 IDEXX
11.6.1 Company Overview
11.6.2 Financial Performance
11.6.3 Product Benchmarking
11.6.4 Strategic Initiatives
11.7 Elanco
11.7.1 Company Overview
11.7.2 Financial Performance
11.7.3 Product Benchmarking
11.7.4 Strategic Initiatives
11.8 Heska Corporation
11.8.1 Company Overview
11.8.2 Product Benchmarking
11.8.3 Strategic Initiatives
11.9 Virbac
11.9.1 Company Overview
11.9.2 Financial Performance
11.9.3 Product Benchmarking
11.9.4 Strategic Initiatives
11.10 B.Braun Vet Care
11.10.1 Company Overview
11.10.2 Financial Performance
11.10.3 Product Benchmarking
11.10.4 Strategic Initiatives
11.11 Covetrus
11.11.1 Company Overview
11.11.2 Financial Performance
11.11.3 Product Benchmarking
11.11.4 Strategic Initiatives
11.12 DRE Veterinary
11.12.1 Company Overview
11.12.2 Financial Performance
11.12.3 Product Benchmarking
11.12.4 Strategic Initiatives
11.13 Televet
11.13.1 Company Overview
11.13.2 Financial Performance
11.13.3 Product Benchmarking
11.13.4 Strategic Initiatives
11.14 Mars Inc.
11.14.1 Company Overview
11.14.2 Financial Performance
11.14.3 Product Benchmarking
11.14.4 Strategic Initiatives
11.15 Phibro Animal Health Corporation
11.15.1 Company Overview
11.15.2 Financial Performance
11.15.3 Product Benchmarking
11.15.4 Strategic Initiatives
11.16 Dechra Pharmaceuticals PLC
11.16.1 Company Overview
11.16.2 Financial Performance
11.16.3 Product Benchmarking
11.16.4 Strategic Initiatives
11.17 Bimeda, Inc.
11.17.1 Company Overview
11.17.2 Financial Performance
11.17.3 Product Benchmarking
11.17.4 Strategic Initiatives
11.18 Midmark Corporation
11.18.1 Company Overview
11.18.2 Financial Performance
11.18.3 Product Benchmarking
11.18.4 Strategic Initiatives
11.19 Thermo Fisher Scientific, Inc.
11.19.1 Company Overview
11.19.2 Financial Performance
11.19.3 Product Benchmarking
11.19.4 Strategic Initiatives
11.20 IDVet
11.20.1 Company Overview
11.20.2 Financial Performance
11.20.3 Product Benchmarking
11.20.4 Strategic Initiatives
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers